Tirzepatide for MASH with fibrosis 15 mg produced a large majority disease-resolution rate versus a small placebo rate: Loomba NEJM 2024 (SYNERGY-NASH)
one 60-count bottle covers a 4-week cycle with margin
It reports pathway-level variants in MTHFR, MTRR, and COMT that describe your baseline methylation and B12 biology, giving upstream context you can bring to a prescriber
For severe deficiencies, especially those with neurological symptoms, a full resolution of symptoms might take several weeks or even months of consistent treatment
This product contains only the peptide as the active component
Our Methyl B12 injections, on the other hand, bypass your digestive system altogether and put the power of Vitamin B12 to work right away in your body